MMWR Morb Mortal Wkly Rep. 1996 Jun 14;45(23):484-7.
During the 1990s, breast or cervical cancer will be diagnosed in an estimated 2 million women in the United States, and 500,000 will die as a result of these diseases. Screening mammography followed by timely and appropriate treatment can reduce breast cancer mortality by 30% for women aged 50-69 years, and routine use of the Papanicolaou (Pap) test followed by timely and appropriate treatment can prevent nearly all deaths from cervical cancer. The Breast and Cervical Cancer Mortality Prevention Act of 1990 established a nationwide, comprehensive public health program for increasing access to breast and cervical cancer screening services for underserved women. This report summarizes the impact of this initiative, CDC's National Breast and Cervical Cancer Early Detection Program (NBCCEDP), during July 1991-September 1995.
在20世纪90年代,预计美国将有200万女性被诊断患有乳腺癌或宫颈癌,其中50万人将死于这些疾病。对于50至69岁的女性,乳腺钼靶筛查并及时进行适当治疗可将乳腺癌死亡率降低30%,而常规使用巴氏涂片检查并及时进行适当治疗几乎可以预防所有宫颈癌死亡。1990年的《乳腺癌和宫颈癌死亡率预防法案》建立了一项全国性的综合公共卫生计划,以增加服务不足妇女获得乳腺癌和宫颈癌筛查服务的机会。本报告总结了这一举措,即疾病控制与预防中心的国家乳腺癌和宫颈癌早期检测计划(NBCCEDP)在1991年7月至1995年9月期间产生的影响。